124 related articles for article (PubMed ID: 19589912)
1. Isolation of stool-derived mucus provides a high yield of colonocytes suitable for early detection of colorectal carcinoma.
White V; Scarpini C; Barbosa-Morais NL; Ikelle E; Carter S; Laskey RA; Miller R; Coleman N
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2006-13. PubMed ID: 19589912
[TBL] [Abstract][Full Text] [Related]
2. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool.
Davies RJ; Freeman A; Morris LS; Bingham S; Dilworth S; Scott I; Laskey RA; Miller R; Coleman N
Lancet; 2002 Jun; 359(9321):1917-9. PubMed ID: 12057556
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
[TBL] [Abstract][Full Text] [Related]
4. Isolation of exfoliated colonocytes from human stool as a new technique for colonic cytology.
Bandaletova T; Bailey N; Bingham SA; Loktionov A
APMIS; 2002 Mar; 110(3):239-46. PubMed ID: 12076277
[TBL] [Abstract][Full Text] [Related]
5. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
Ahmed FE; Ahmed NC; Gouda MM; Vos PW; Bonnerup C
Methods Mol Biol; 2018; 1765():203-215. PubMed ID: 29589310
[TBL] [Abstract][Full Text] [Related]
6. Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis.
Koga Y; Yasunaga M; Moriya Y; Akasu T; Fujita S; Yamamoto S; Kozu T; Baba H; Matsumura Y
Cancer Sci; 2008 Oct; 99(10):1977-83. PubMed ID: 19016757
[TBL] [Abstract][Full Text] [Related]
7. Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications.
Loktionov A; Soubieres A; Bandaletova T; Francis N; Allison J; Sturt J; Mathur J; Poullis A
Br J Cancer; 2020 Jul; 123(2):252-260. PubMed ID: 32398859
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
[TBL] [Abstract][Full Text] [Related]
9. DNA integrity as a potential marker for stool-based detection of colorectal cancer.
Boynton KA; Summerhayes IC; Ahlquist DA; Shuber AP
Clin Chem; 2003 Jul; 49(7):1058-65. PubMed ID: 12816901
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates.
Ayaru L; Stoeber K; Webster GJ; Hatfield AR; Wollenschlaeger A; Okoturo O; Rashid M; Williams G; Pereira SP
Br J Cancer; 2008 May; 98(9):1548-54. PubMed ID: 18414413
[TBL] [Abstract][Full Text] [Related]
11. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
[TBL] [Abstract][Full Text] [Related]
12. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
[TBL] [Abstract][Full Text] [Related]
13. [Colorectal exfoliated cell in stool and its nuclear DNA quantitative analysis for diagnosis of colorectal cancer].
Fan RY; Li SR; Wu ZT; Wu X; Chen ZM
Ai Zheng; 2002 Jul; 21(7):776-80. PubMed ID: 12479106
[TBL] [Abstract][Full Text] [Related]
14. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
Zou H; Harrington J; Rego RL; Ahlquist DA
Clin Chem; 2007 Sep; 53(9):1646-51. PubMed ID: 17712002
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.
Loktionov A; O'Neill IK; Silvester KR; Cummings JH; Middleton SJ; Miller R
Clin Cancer Res; 1998 Feb; 4(2):337-42. PubMed ID: 9516920
[TBL] [Abstract][Full Text] [Related]
16. Clusterin in stool: a new biomarker for colon cancer screening?
Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
[TBL] [Abstract][Full Text] [Related]
17. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
18. [The molecular screening of the stool for the colorectal carcinoma].
Voboril R; Weberová J; Dvorák J
Rozhl Chir; 2005 Jun; 84(6):281-5. PubMed ID: 16149221
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening.
Kunte DP; DelaCruz M; Wali RK; Menon A; Du H; Stypula Y; Patel A; Backman V; Roy HK
PLoS One; 2012; 7(9):e45591. PubMed ID: 23049818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
